December 2025 in “Cell Communication and Signaling” Minoxidil may help treat myelodysplastic syndrome without harming normal blood cell production.
8 citations
,
January 2020 in “Journal of Cutaneous Medicine and Surgery” Oral minoxidil may improve hair loss in men and women, but has some side effects.
June 2025 in “International Journal of Research in Dermatology” The combination of tretinoin gel and minoxidil effectively improves hair growth and satisfaction in people with androgenetic alopecia.
September 1992 in “Journal of Dermatological Science” 1 citations
,
April 2022 in “JAAD case reports” A woman developed a rare scalp condition after starting minoxidil, which was resolved with specific shampoo and solution.
1 citations
,
January 2016 in “Journal of Headache & Pain Management” Discontinuing topical minoxidil can resolve headaches and dizziness.
25 citations
,
November 1987 in “British Journal of Dermatology” Minoxidil didn't increase scalp blood flow for hair growth, but hexyl nicotinate did.
51 citations
,
October 1980 in “The New England Journal of Medicine” Minoxidil lowers blood pressure effectively but may cause unwanted hair growth and other side effects.
August 2024 in “Skin Appendage Disorders” Long-term use of high-dose topical minoxidil can cause thickened, ridged scalp.
34 citations
,
January 1987 in “Dermatology” Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.
January 2021 in “Journal of clinical & experimental dermatology research” The new 5% minoxidil formulation without propylene glycol effectively promotes hair growth with fewer side effects and better user satisfaction.
September 2010 in “Reactions weekly” The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.
34 citations
,
November 1987 in “Archives of Dermatology” Oral minoxidil helps hair regrowth in 80% of alopecia patients, but only 18% see cosmetic improvement.
149 citations
,
June 2002 in “British Journal of Dermatology” Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.
January 2023 in “Skin appendage disorders” Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.
2 citations
,
April 1989 in “Archives of Dermatology” Minoxidil (Rogaine) effectively promotes hair growth in male pattern baldness.
September 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” Combining minoxidil with other treatments like platelet-rich plasma or finasteride increases hair growth more than minoxidil alone.
August 2023 in “Stem Cell Research & Therapy” Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.
January 2023 in “TNOA journal of ophthalmic science and research” Minoxidil may cause vision problems.
6 citations
,
January 2021 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.
Combining minoxidil, finasteride, and growth factors improves hair growth and reduces hair loss.
January 2025 in “Lasers in Surgery and Medicine” Combining fractional CO2 laser with minoxidil is more effective for hair growth in alopecia areata than minoxidil alone.
27 citations
,
November 2013 in “Dermatologic Therapy” New test predicts if hair loss treatment will work.
August 2024 in “Bioimpacts” Kopexil is an effective and safe hair growth treatment.
May 2015 in “Journal of The American Academy of Dermatology” 5% minoxidil foam helps women with thinning hair.
11 citations
,
January 2010 in “Indian Journal of Dermatology, Venereology and Leprology” Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.
January 2026 in “Dermatologic Therapy” Combining laser treatment with minoxidil is more effective for hair growth in men than using minoxidil alone.
21 citations
,
October 1978 in “The Journal of Clinical Pharmacology”